Objective:To investigate the therapeutic effect of endoscopic injection sclerotherapy(EIS)in patients with grade Ⅰ～Ⅲ internal hemorrhoids.Methods:A total of 100 patients with grade Ⅰ～Ⅲ internal hemorrhoids who were treated in Yichang Central People's Hospital from February 2023 to April 2024 were selected.Among them,patients who received EIS were assigned to the observation group(n=43),and those who received procedure for prolapsing and hemorrhoids(PPH)were assigned to the control group(n=57).The clinical efficacy of the two groups was compared.Results:There was no significant difference in the treatment efficiency between the two groups.Compared with the control group,the operation time[(16.53±4.61)min vs(29.65±7.84)min],intraoperative blood loss[(7.14±2.32)mL vs(18.62±4.22)mL],number of analgesic administrations[(4.15±1.35)times vs(9.87±2.37)times],hospital stay[(5.45±1.14)days vs(7.64±1.52)days],and hospitalization expenses[(4.13±1.12)thousand yuan vs(6.63±1.24)thousand yuan]were significantly reduced in the observation group,and the pain intensity at 24 hours and 30 days after surgery was significantly lower in the observation group(all P＜0.05).The incidence of complications in the observation group(9.30％vs 45.61％)was significantly lower than that in the control group(P＜0.05).Conclusion:There was no significant difference in the treatment efficiency between EIS and PPH in patients with grade Ⅰ～Ⅲ internal hemorrhoids.Patients receiving EIS had shorter operation time,less intraoperative blood loss,milder postoperative pain,lower incidence of complications,and lower hospitalization expenses.
endoscopic injection sclerotherapy(EIS)procedure for prolapsing and hemorrhoids(PPH)internal hemorrhoids
国家科技期刊平台
NSTL
万方数据
